Not a Bad Year, After All
Source: Life Science Leader
By Wayne Koberstein, Executive Editor, Life Science Leader
Follow Me On Twitter @WayneKoberstein
Perhaps the greatest heights of the biopharma sector will never be seen again — but don’t overlook the good ti mes now. Th at is the central message in the following interview with Peter Meath, who heads the Life Science Group at J.P. Morgan’s Commercial Banking business. Meath also comments on the current industry environment and offers seasoned advice to novice entrepreneurs for turning a company’s novel science into a viable business.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more